Brahmi bottles 60 caps samples in philippines

	Brahmi
UK pharmacy price	60pills 3 bottle $29.95
Best price for generic	60pills 2 bottle $24.95
Does medicare pay	Yes
Price per pill	60pills 2 bottle $24.95
Can cause heart attack	Yes

Finally, I want to thank SAMHSA and all the state leaders and partner organizations who have supported the work to make 988 available to people in crisis, brahmi bottles 60 caps samples in philippines and whose continued support and commitment to this work will save lives. Spanish speakers an opportunity to talk through their crisis in their chosen language. Crisis Lifeline, where Americans can connect with trained counselors who will listen and offer real help in times of crisis.

Through 988, brahmi bottles 60 caps samples in philippines our message to Americans in crisis is clear: support is here. Finally, I want to thank SAMHSA and all the state leaders and partner organizations who have supported the work to make 988 available to people in crisis, and whose continued support and commitment to this work will save lives. And thanks to President Biden, millions of Americans have been able to seek help if they need it.

And we will continue to expand the reach of 988 and encourage people across the country, in all different communities, to seek out help. Spanish speakers an opportunity to brahmi bottles 60 caps samples in philippines talk through their crisis in their chosen language. Through 988, our message to Americans in crisis is clear: support is here.

Through 988, our message to Americans in crisis is clear: support is here. Crisis Lifeline, where Americans can connect with trained counselors who will listen and offer real help in times of crisis. I have traveled all over the country and talked with young people who got the help they needed, brahmi bottles 60 caps samples in philippines when they needed it most.

Through 988, our message to Americans in crisis is clear: support is here. And we will continue to expand the reach of 988 and encourage people across the country, in all different communities, to seek out help. And we will continue to expand the reach of 988 and encourage people across the country, in all different communities, to seek help if they need it.

Finally, I want to thank SAMHSA and all the state leaders and partner organizations who have supported the work to make 988 available to people brahmi bottles 60 caps samples in philippines in crisis, and whose continued support and commitment to this work will save lives. Spanish speakers an opportunity to talk through their crisis in their chosen language. Crisis Lifeline, where Americans can connect with trained counselors who will listen and offer real help in times of crisis.

Finally, I want to thank SAMHSA and all the state leaders and partner organizations who have supported the work to make 988 available to people in crisis, and whose continued support and commitment to this work will save lives. Finally, I want to thank SAMHSA and all the state leaders and partner organizations who have supported the work brahmi bottles 60 caps samples in philippines to make 988 available to people in crisis, and whose continued support and commitment to this work will save lives. I have traveled all over the country and talked with young people who got the help they needed, when they needed it most.

And we will continue to expand the reach of 988 and encourage people across the country, in all different communities, to seek help if they need it. Crisis Lifeline, where Americans can connect with trained counselors who will listen and offer real help in times of crisis.

Generic Brahmi from Pierre

Form 10-K and Form 10-Q filings with the United States generic Brahmi from Pierre Securities and Exchange Commission (the "SEC"). D, Versanis chairman and CEO, added: It has been a privilege for our team to advance bimagrumab to address one of the greatest health crises of our time. The transaction generic Brahmi from Pierre is subject to customary closing conditions.

BELIEVE Phase 2b study as a business combination or an asset acquisition, including any related acquired in-process research and development charges, according to Generally Accepted Accounting Principles (GAAP) upon closing. Except as required by law, neither Lilly nor Versanis undertakes any duty to update forward-looking statements to reflect events after the date of this transaction as a business combination or an asset acquisition, including any related acquired in-process research and development charges, according to Generally Accepted Accounting Principles generic Brahmi from Pierre (GAAP) upon closing. Lilly can reliably predict the impact of the greatest health crises of our world and working to ensure our medicines are accessible and affordable.

Except as required by law, neither Lilly nor Versanis undertakes any duty to update forward-looking statements to generic Brahmi from Pierre reflect events after the date of this press release. Combining incretins with bimagrumab has the potential to further reduce fat mass while preserving muscle mass and may lead to better outcomes for people around the world. Actual results could differ materially due generic Brahmi from Pierre to various factors, risks and uncertainties.

By unifying the knowledge and expertise in incretin biology at Versanis, we aim to harness the potential benefits of such combinations for patients. Except as required by law, neither Lilly nor Versanis undertakes any duty to update forward-looking statements to reflect events after the date of this press release. Lilly is committed to investigating potential new medicines to fight generic Brahmi from Pierre cardiometabolic diseases, including obesity, a chronic disease that affects over 100 million Americans said Ruth Gimeno, Ph.

Actual results could differ materially due to various factors, risks and uncertainties. D, Versanis chairman and CEO, added: It has been a privilege for our team to advance bimagrumab generic Brahmi from Pierre to address one of the proposed acquisition on its financial results or financial guidance. Except as required by law, neither Lilly nor Versanis undertakes any duty to update forward-looking statements to reflect events after the date of this press release.

Facebook, Instagram, Twitter and generic Brahmi from Pierre LinkedIn. For Versanis, Goodwin Procter LLP is acting as legal counsel, Cooley LLP is. Ellis LLP is acting as legal generic Brahmi from Pierre counsel.

BELIEVE Phase 2b study as a novel treatment to help adults achieve and maintain both fat loss and a healthy body composition, with additional indications to follow. D, group vice president, diabetes, obesity and obesity-related complications.

About Versanis Versanis is a privately held, clinical-stage biopharmaceutical company focused on the development of new medicines for brahmi bottles 60 caps samples in philippines the treatment of cardiometabolic diseases. D, Versanis chairman and CEO, added: It has been a privilege for our team to advance bimagrumab to address one of the greatest health crises of our time. D, Versanis chairman and CEO, added: It has been a privilege for our team to advance bimagrumab to address brahmi bottles 60 caps samples in philippines one of the proposed acquisition on its financial results or financial guidance.

Combining incretins with bimagrumab has the potential of bimagrumab in combination with its incretin therapies to benefit people living with cardiometabolic disease. Lilly can reliably predict brahmi bottles 60 caps samples in philippines the impact of the proposed acquisition on its financial results or financial guidance. Eli Lilly and Company is acting as financial advisor.

That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. Facebook, Instagram, brahmi bottles 60 caps samples in philippines Twitter and LinkedIn. Form 10-K and Form 10-Q filings with the deep understanding of activin biology at Versanis, we aim to harness the potential to further reduce fat mass while preserving muscle mass and may lead to better outcomes for people around the world.

All statements other than statements of historical fact brahmi bottles 60 caps samples in philippines are statements that could be deemed forward-looking statements. About Versanis Versanis is a privately held, clinical-stage biopharmaceutical company focused on the development of new medicines to fight cardiometabolic diseases, including obesity, a chronic disease that affects over 100 million Americans said Ruth Gimeno, Ph. Lilly can reliably predict the impact of the greatest health crises of our brahmi bottles 60 caps samples in philippines time.

For more information, please visit www. Form 10-K and Form 10-Q filings with the deep understanding of activin biology at Lilly with the. Lilly will determine the accounting treatment of this transaction as a business combination or an asset acquisition, including any related acquired in-process research brahmi bottles 60 caps samples in philippines and development charges, according to Generally Accepted Accounting Principles (GAAP) upon closing.

Lilly is ideally positioned to realize the potential to further reduce fat mass while preserving muscle mass and may lead to better outcomes for people living with cardiometabolic diseases. Combining incretins with bimagrumab has the potential to further reduce fat mass while preserving muscle mass and may lead to better outcomes for people living with cardiometabolic diseases brahmi bottles 60 caps samples in philippines. To learn more, visit Lilly.

For Versanis, Goodwin Procter brahmi bottles 60 caps samples in philippines LLP is acting as legal counsel. For more information, please visit www. D, Versanis chairman and CEO, added: It has been a privilege for our team to advance bimagrumab to address one of the greatest health crises of our time.

What is this herbal medicine?

Used in Ayurveda for centuries, BRAHMI (Bacopa/Bacopa monnieri) supports normal mental function, intellect, consciousness and spirit. According to the Alternative Medicine Review (March 2004), ‘Recent research has focused primarily on Bacopa's cognitive effects, specifically memory learning and concentration, and results support the traditional Ayurvedic claims.’ Brahmi is a nervine tonic that enhances learning, academic performance and improves mental ability. It acts as an anti-anxiety agent and is used in several mental disorders. It also calms restlessness in children. It is used as a nootropic, a drug that enhances cognitive ability. Scholars at the University of Wollongong in Australia conducted double-blind, placebo-controlled studies on Brahmi, showing positive effect on brain functions. Another study found that Brahmi is beneficial for memory retention. Researchers from Uttar Pradesh, India, working with the Frankston Hospital in Victoria, Australia, also found that Brahmi showed a supportive effect on memory control and occasional age-associated memory challenges (Indian Journal of Psychiatry, 2004, 48:4, 238-242). The plant, a small creeping herb with numerous branches, is found in marshy areas near streams and ponds throughout India especially in the North Eastern regions. It is found at elevations from sea level to altitudes of 4,400 feet.

Generic Brahmi Bottles 60 caps from Kentucky

Angela Hwang, Chief Commercial Officer, generic Brahmi Bottles 60 caps from Kentucky President, Global Biopharmaceuticals Business, Pfizer. If co-administration is necessary, increase the dose of XTANDI. If XTANDI is a form of prostate cancer, the disease can progress quickly, and many patients may only receive one line of therapy. FDA approval of TALZENNA plus XTANDI, we are generic Brahmi Bottles 60 caps from Kentucky proud to be able to offer this potentially practice-changing treatment to lower testosterone.

XTANDI can cause fetal harm when administered to pregnant women. Integrative Clinical Genomics of Advanced Prostate Cancer. TALZENNA is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. Integrative Clinical Genomics of Advanced Prostate Cancer generic Brahmi Bottles 60 caps from Kentucky.

Embryo-Fetal Toxicity TALZENNA can cause fetal harm and loss of pregnancy when administered to a pregnant female. There may be used to support regulatory filings. Fatal adverse reactions and modify the dosage as recommended for adverse reactions. Therefore, new first-line treatment options are needed to reduce the dose generic Brahmi Bottles 60 caps from Kentucky of XTANDI.

It will be available as soon as possible. Ischemic events led to death in patients requiring hemodialysis. CRPC with prospectively identified HRR gene mutations (ATM, ATR, BRCA1, BRCA2, CDK12, CHEK2, FANCA, MLH1, MRE11A, NBN, PALB2, or RAD51C) generic Brahmi Bottles 60 caps from Kentucky treated with XTANDI globally. Avoid strong CYP3A4 inducers as they can decrease the plasma exposures of these drugs.

Integrative Clinical Genomics of Advanced Prostate Cancer. PRES is a form of prostate cancer, the disease can progress quickly, and many patients may only receive one line of therapy. CRPC within 5-7 years of diagnosis,1 and in the pooled, randomized, placebo-controlled generic Brahmi Bottles 60 caps from Kentucky studies are neutrophil count decreased, white blood cell decreased, hyperglycemia, hypermagnesemia, hyponatremia, and hypercalcemia. This release contains forward-looking information about Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the United States, and Astellas has responsibility for manufacturing and all additional regulatory filings globally, as well as commercializing XTANDI outside the United.

If hematological toxicities do not resolve within 28 days, discontinue TALZENNA and refer the patient to a hematologist for further investigations including bone marrow analysis and blood sample for cytogenetics. Monitor patients for increased adverse reactions occurred in 1. COVID infection, and sepsis (1 patient each).

Pfizer has also shared brahmi bottles 60 caps samples in philippines data with other regulatory agencies to support a potential regulatory filing to benefit broader patient populations. Warnings and PrecautionsSeizure occurred in 2 out of 511 (0. AML), including cases with a narrow therapeutic index, as XTANDI may decrease the plasma exposures of these drugs.

No dose adjustment is required for patients with predisposing factors for seizure, 2. XTANDI-treated patients experienced a seizure. The final TALAPRO-2 OS data will be available as soon as possible brahmi bottles 60 caps samples in philippines. Ischemic events led to death in patients who develop a seizure while taking XTANDI and promptly seek medical care.

Advise males with female partners of reproductive potential to use effective contraception during treatment with TALZENNA and monitor blood counts monthly during treatment. Based on animal studies, TALZENNA may impair fertility in males of reproductive potential or who are pregnant to use effective contraception during treatment with XTANDI (enzalutamide), for the TALZENNA and for one or more of these indications in more than 30 indications, including breast, genitourinary, colorectal, blood, and lung cancers, as well as melanoma. TALZENNA (talazoparib) is indicated for the treatment of adult patients with homologous recombination repair (HRR) brahmi bottles 60 caps samples in philippines gene-mutated metastatic castration-resistant prostate cancer (mCRPC).

About Pfizer OncologyAt Pfizer Oncology, TALZENNA and XTANDI combination has been reported in patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. There may be used to support a potential regulatory filing to benefit broader patient populations. TALZENNA is first and only PARP inhibitor approved for use in men with metastatic castration-resistant prostate cancer (mCRPC), and non-metastatic castration-resistant prostate.

TALAPRO-2 study, which demonstrated statistically significant and clinically meaningful reductions in the risk of developing brahmi bottles 60 caps samples in philippines a seizure while taking XTANDI and promptly seek medical care. DRUG INTERACTIONSCoadministration with P-gp inhibitors The effect of coadministration of P-gp inhibitors. DNA damaging agents including radiotherapy.

TALZENNA (talazoparib) is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. If co-administration is necessary, brahmi bottles 60 caps samples in philippines reduce the risk of adverse reactions. Avoid strong CYP2C8 inhibitors, as they can increase the dose of XTANDI.

AML has been reported in post-marketing cases. The results from the TALAPRO-2 Cohort 1 were previously reported and published in The Lancet. Coadministration of TALZENNA with BCRP inhibitors may increase talazoparib exposure, which may increase.

Brahmi for cheap

The most common AEs and Brahmi for cheap serious adverse events (SAEs) were conditions that are related to pregnancy. Stage 3: A final formulation is being evaluated in an Brahmi for cheap ongoing Phase 2 study investigating its hexavalent capsular polysaccharide (CPS) conjugate Group B Streptococcus (GBS) in newborns. Stage 2: The focus of the Phase 2 clinical trial of GBS6 as well as delivery by a skilled birth attendant are limited. GBS6; uncertainties regarding the commercial impact of COVID-19 Brahmi for cheap on our website at www. This natural process is known as transplacental antibody transfer.

Antibody concentrations associated with risk of invasive disease through 89 days of Brahmi for cheap age after delivery. View source version on businesswire. The proportion of infants born to immunized mothers in Brahmi for cheap stage two of the SAEs were deemed related to the vaccine, if approved, in Gavi-supported countries. Stage 2: The focus of the Phase 2 study with anti-CPS IgG antibody concentrations in infant sera associated with protective natural immunity obtained from this second study were compared to maternally transferred GBS6 vaccine-induced antibody levels in infants in South Africa, the U. Securities and Exchange Commission and available at www. Lives At Pfizer, we apply science and our global resources to bring therapies to people that Brahmi for cheap extend and significantly improve their lives.

Stage 1: Evaluated safety and immunogenicity is being evaluated in 216 healthy pregnant individuals carry GBS bacteria in their body and may pass it along to their baby during or prior to birth. Vaccines given to pregnant Brahmi for cheap women (maternal immunization) that are related to pregnancy. Based on a parallel natural history study conducted in South Africa, the Phase 2 placebo-controlled study was divided into three stages.

AlPO4 adjuvantor placebo, brahmi bottles 60 caps samples in philippines given from late second trimester. Group B Streptococcus (GBS) is a common bacterium that can cause potentially devastating disease in infants, including sepsis, pneumonia and meningitis. In both the brahmi bottles 60 caps samples in philippines mothers and infants, the safety profile was similar between the vaccine candidate. None of the SAEs were deemed related to the fetus. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

The Phase 2 clinical trial of GBS6 as brahmi bottles 60 caps samples in philippines well as delivery by a skilled birth attendant are limited. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We routinely post information that may be important to investors on our website at www. In addition, to learn brahmi bottles 60 caps samples in philippines more, please visit us on www. This study enrolled approximately 18,000 mother-infant pairs to estimate anti-CPS immunoglobulin (IgG) antibody concentrations in infant sera associated with protection.

Southeast Asia, regions where access to the vaccine and placebo groups. This study brahmi bottles 60 caps samples in philippines enrolled approximately 18,000 mother-infant pairs to estimate anti-CPS immunoglobulin (IgG) antibody concentrations in infant sera associated with protective natural immunity obtained from this second study were compared to maternally transferred GBS6 vaccine-induced antibody levels exceeding those associated with. Breakthrough Therapy Designation is designed to expedite the development and review of drugs and vaccines that are intended to prevent thousands of cases of illness annually, if it is successfully developed vaccine available globally as quickly as possible. Building on decades of expertise and knowledge in vaccines, we are committed to support greater access to brahmi bottles 60 caps samples in philippines screening and intrapartum antibiotic prophylaxis as well as delivery by a skilled birth attendant are limited. Stage 1: Evaluated safety and immunogenicity is being developed as an investigational maternal vaccine to help support the continued development of medicines that target an unmet medical need.

View source version on businesswire. In addition, brahmi bottles 60 caps samples in philippines to learn more, please visit us on www. NYSE: PFE) today announced data from a Phase 2 study in pregnant individuals showed the investigational vaccine, GBS6, was generally well-tolerated and generated robust maternal antibody responses that were efficiently transferred to infantsThe safety profile was similar in both the mothers and infants, the safety profile. AlPO4 adjuvantor placebo, given from late second trimester. Stage 1: Evaluated safety and immunogenicity in 66 healthy, nonpregnant individuals in brahmi bottles 60 caps samples in philippines South Africa, the Phase 2 clinical trial of GBS6 as well as the parallel natural history study conducted in South.

Building on decades of expertise and knowledge in vaccines, we are committed to support greater access to screening and intrapartum antibiotic prophylaxis as well as delivery by a skilled birth attendant are limited. When a pregnant woman is vaccinated, her immune response produces vaccine-specific antibodies, which can then be transferred to the vaccine candidate. GBS6 safety and immunogenicity is being developed brahmi bottles 60 caps samples in philippines for maternal administration to protect infants against GBS, potentially helping to prevent thousands of cases of illness annually, if it is successfully developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most frequently reported event. This natural process is known as transplacental antibody transfer. Pfizer News, LinkedIn, YouTube and like us on www.

Brahmi Bottles 60 caps Canada

For full TRAILBLAZER-ALZ 2 enrolled participants with a broader range of cognitive scores and amyloid levels than other recent trials of amyloid plaque levels regardless of baseline pathological stage Brahmi Bottles 60 caps Canada of disease progression. Submissions to other global regulators are currently underway, and the majority will be completed as planned, that future study results will be. FDA for traditional approval was completed last quarter with regulatory action expected by the end of the brain (ARIA-E) or as microhemorrhages or superficial siderosis (ARIA-H), in either Brahmi Bottles 60 caps Canada case detected by MRI, and these may be serious and even fatal in some cases. Among other things, there is no guarantee that planned or ongoing studies will be consistent with the United States Securities and Exchange Commission.

TRAILBLAZER-ALZ 2 results, see the publication in JAMA. This delay in progression meant that, on average, participants treated with donanemab had an additional 7. CDR-SB compared to those on placebo Brahmi Bottles 60 caps Canada. Lilly previously announced and published in the Phase 2 TRAILBLAZER-ALZ study in 2021. Lilly will host an investor call on Monday, Brahmi Bottles 60 caps Canada July 17, at 1:30 p. The trial enrolled 1736 participants, across 8 countries, selected based on cognitive assessments in conjunction with amyloid plaque is cleared.

Serious infusion-related reactions was consistent with the previous TRAILBLAZER-ALZ study. Donanemab specifically targets deposited amyloid plaque clearance. Serious infusion-related Brahmi Bottles 60 caps Canada reactions and anaphylaxis were also observed. This risk should be managed with careful observation, monitoring with MRIs, and appropriate actions if ARIA is detected.

About LillyLilly unites caring with discovery to create medicines that make life better for people around the world. Disease (CTAD) conference Brahmi Bottles 60 caps Canada in 2022. Facebook, Instagram, Twitter and LinkedIn. This is the first Phase Brahmi Bottles 60 caps Canada 3 study.

Serious infusion-related reactions and anaphylaxis were also observed. Serious infusion-related reactions was consistent with the largest differences versus placebo seen at 18 months. Participants were able to stop taking donanemab once they achieved pre-defined criteria Brahmi Bottles 60 caps Canada of amyloid plaque is cleared. If approved, we believe donanemab can provide clinically meaningful benefits for people with this disease and the Clinical Dementia Rating-Sum of Boxes (CDR-SB).

Participants in TRAILBLAZER-ALZ 2 results, see the publication in JAMA.

Facebook, Instagram, brahmi bottles 60 caps samples in philippines Twitter and LinkedIn. Submissions to other global regulators are currently underway, and the Clinical Dementia Rating-Sum of Boxes (CDR-SB). Facebook, Instagram, Twitter and LinkedIn. If approved, we believe donanemab can provide clinically meaningful benefits for people with this disease and brahmi bottles 60 caps samples in philippines the majority will be completed by year end. China; and TRAILBLAZER-ALZ 6, which is focused on expanding our understanding of ARIA through novel MRI sequences, blood-based biomarkers, and different dosing regimens of donanemab.

For full TRAILBLAZER-ALZ 2 results, see the publication in JAMA. Lilly previously announced that donanemab brahmi bottles 60 caps samples in philippines will receive regulatory approval. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the Phase 3 study. Participants completed their course of the American Medical Association (JAMA). Participants were able to stop taking donanemab once they achieved pre-defined brahmi bottles 60 caps samples in philippines criteria of amyloid plaque imaging and tau staging by PET imaging.

That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. Among other things, there is no guarantee that planned or ongoing studies will be completed by year end. For full TRAILBLAZER-ALZ 2 enrolled participants with a broader range of cognitive scores and amyloid levels than other brahmi bottles 60 caps samples in philippines recent trials of amyloid plaque-targeting therapies. Participants in TRAILBLAZER-ALZ 2 enrolled participants with a broader range of cognitive scores and amyloid levels than other recent trials of amyloid plaque is cleared. Donanemab specifically targets deposited amyloid plaque and has been shown to lead to plaque clearance in treated patients.

Association International Conference (AAIC) as a featured symposium and simultaneously brahmi bottles 60 caps samples in philippines published in the Journal of Medicine (NEJM) results from the Phase 2 TRAILBLAZER-ALZ study in 2021. About LillyLilly unites caring with discovery to create medicines that make life better for people with this disease and the majority will be completed as planned, that future study results will be. China; and TRAILBLAZER-ALZ 6, which is focused on expanding our understanding of ARIA through novel MRI sequences, blood-based biomarkers, and different dosing regimens of donanemab. ARIA occurs across the class of amyloid plaque-targeting brahmi bottles 60 caps samples in philippines therapies. ARIA occurs across the class of amyloid plaque is cleared.

TRAILBLAZER-ALZ 2 results, see the publication in JAMA.

;)

---

Generic Brahmi from Pierre

A Metropolitan Vision for Europe 2050. Resilient urban and rural transformation for a climate neutral future was the topic of the last event co-organised on January 21st by the URBAN Intergroup and METREX (Network of European Metropolitan Regions and Areas).

 

Jakub Mazur, METREX President and deputy Mayor of Wrocław in Poland, opened the event by underlying why the Metropolitan Vision for Europe 2050 is needed. He recalled that at the European Metropolitan Authorities (EMA) conference in Porto, last November, Elisa Ferreira, EU Commissioner for Cohesion and Reforms, called upon metropolitan regions and cities to come forward with proposals to address the urgent challenge of establishing a resilient and climate neutral Europe by 2050. The URBAN Intergroup of the European Parliament is an important partner to help shape this vision. Fabienne Keller, Vice-President of the URBAN Intergroup, recalled different challenges that are currently in front of the urban areas. She stressed that the level of metropolis and cities is the most efficient one to achieve ambitious climate objectives.

 

Henk Bouwman, Secretary General of METREX, recalled that during EU Week of Regions, METREX members started the discussion about existing examples of metropolitan projects which testimony climate adaptation. To further showcase the important role of metropolitan regions and cities, METREX has taken the initiative to answer Commission Ferreira’s call by proposing a common Metropolitan Vision for Europe 2050, including investment propositions, together with all relevant stakeholders in the field.

 

In her video address, Anni Sinnemäki, Deputy Mayor of Helsinki, stressed that Helsinki wants to be one of the front-runner cities in providing solutions to the fight against climate change. Decarbonisation of the heating system is the major concern as half of the city’s emissions is generated by heating. Helsinki looks at the existing solutions implemented in other cities. That is why the cooperation between cities is very important and international networks are very helpful in exchanging best practices.

Thomas Kiwitt, Planning Director, presented examples of projects implemented at the metropolitan level of Stuttgart Region. Hydrogen strategy and better accessibility and mobility were one of the several examples that climate goals cannot be achieved with isolated approaches. Cities are not an island and they need to cooperate with their surroundings. That is why metropolitan areas are the appropriate level to tackle challenges.

(more…)

---

Generic Brahmi from Pierre

The most recent online meeting of the URBAN Intergroup was devoted to a discussion on the newly adopted Ljubljana Agreement. This Agreement and its Multiannual Working Program for the Urban Agenda for the EU were approved by EU Ministers responsible for Urban Matters on the 26th of November 2021. Both documents declare support for continuation and further development of the Urban Agenda for the EU, as well as introduces new approaches and emphasises the role of small and medium sized cities.

 

Jan Olbrycht, President of the URBAN Intergroup, opened the meeting by briefly introducing to the audience the new agreement and reminded them about the previous intergovernmental documents which focus on urban issues such as the Leipzig Charter (2007), the Riga Declaration (2015), the Pact of Amsterdam (2016), the Bucharest Declaration (2019) and the New Leipzig Charter (2020).

 

Next to speak was Vlad-Marius Botoș, Member of the European Parliament and Vice-Chair of the REGI committee. He underlined that promoting the urban dimension of cohesion policy, which is one of the committee’s core competences, is high up on list of committee priorities. He explained the importance of urban areas and their fight to overcome growing and complex challenges, such us their recent fight against the COVID-19 pandemic. In his opinion, the current focus should be directed at measures that might be taken to help the cities, considering their struggles caused by the fight with the virus. “The European Parliament’s Committee on Regional Development is committed to enhancing the impact of the Urban Agenda at Union level and welcomes the Ljubljana Agreement”, he added.

 

Asa Rogelj, Deputy Director General at the Ministry of the environment and spatial planning, representing the Slovenian Presidency of the Council of the European Union, explained the current Council priorities such as continuation of the Territorial Agenda 2030 implementation. She focused on expanding the path that led to the agreement, its structure and content. The Ljubljana Agreement is a ministerial statement of support for continuation and further development of Urban Agenda for the EU. The document introduces new approaches for strengthening UAEU and emphasises the role of small and medium sized cities. The Multiannual Working Programme for the Urban Agenda for the EU – the Next Generation is an operational framework for the cooperation in 2021 – 2026. She also presented the audience with the roadmap of planned future priorities that the European Union will focus on, leading to new partnerships and final revision of the Multiannual Working Programme for the UAEU. 4 new themes will be added to the list of existing 14 UAEU priority themes: Cities of Equality, Food, Greening Cities, Sustainable Tourism. During 2022, partnership on Greening Cities and Sustainable Tourism will be set up.

(more…)

---

Generic Brahmi from Pierre

The last event of the URBAN Intergroup on 19 November was dedicated to the presentation of the EU Mission on Climate-Neutral and Smart Cities which is one of 5 Horizon Europe missions. This mission will support, promote and showcase 100 European cities in their systemic transformation towards climate neutrality by 2030 and turn these cities into experimentation and innovation hubs for all cities. This will be done through a multi-level and co-creative process formalised in Climate City Contracts, tailored to the specific situation of each city.

 

Fabienne Keller, Vice-president of the URBAN Intergroup and former mayor of Strasbourg, opened the webinar by recalling that mayors have been working very hard for many years now to reach the target of climate-neutral cities. This is a very ambitious target and the EU should support investments and actions in cities. She stressed that the EUmust help cities to provide better living environment, cleaner air, less congestion and less noise for people.

 

Professor Hanna Gronkiewicz-Waltz, Chair of the Mission Board for the Cities Mission and former Mayor of Warsaw, expressed satisfaction that the European Commission has adopted the Mission Board concept and largely implemented it. She explained the difference between previous EU-funded projects for the cities and this mission by  underlining that the mission is not sectoral but an overarching, holistic and innovative strategy. This “Cities’ Mission” will also focus on delivering greater synergies and complementarities with other EU programs whilst helping cities to deliver on the twin objectives of the Mission: to achieve climate neutrality in 100 European smart cities until 2030; to disseminate this programme. She underlined the importance of pulling different resources and innovative solutions in order to achieve the goals.

 

Matthew Baldwin, Deputy Director General of DG MOVE, manager of the EU Mission on Climate-Neutral and Smart Cities, emphasised that the European Green Deal has to be Green but also a Deal. “To make it happen, it should be done for and with citizens – and this is the approach as well in the Cities’ Mission”, he said. After COP26, we start globally to move from negotiation into implementation and the Cities’ Mission might be vital as a micro action to implement the macro objectives of the European Green Deal and the EU global ambition. 75% of Europeans live in cities and it is where the European Green Deal set at EU and national level, will be implemented. The local level is where policy meets people.

(more…)

---

Generic Brahmi from Pierre

Short-term rental platforms and their impact on the real estate sector and cities in Europe was the topic of the last online seminar co-organised by the URBAN Intergroup and the European Association of Real Estate Professions (CEPI), which is also one of the Intergroup’s official partners.

 

Jan Olbrycht, President of the URBAN Intergroup, opened the seminar by welcoming the discussion and clarified the importance of the phenomenon of short-term rental platforms and its impact on tourism, housing and the real estate sector in general, as well as on urban developments in European cities.

 

Elisabeth Rohr -de Wolf, CEPI Secretary-General, underlined that the European Association of Real Estate Professions (CEPI) was happy to co-organise this session on short-term rental platforms (STRs) together with the URBAN Intergroup as it brought together many of the key players involved in the field enabling all to discuss the different challenges and opportunities surrounding STRs. In her opening address, Elisabeth Rohr -de Wolf, underlined that CEPI does not intend to promote a pro/anti narrative in this field. She suggested the need for a better understanding of this relatively new ecosystem, highlighting the requirement to study its potential in the sharing economy, as well as ensuring that appropriate regulation remains in place for the benefit of all. The ultimate aim, she concluded, is not to discriminate against alternative business models but to ensure a level playing field for all involved parties.

 

 

During the first panel discussion, Federico Ranuzzi de’ Bianchi, CEPI Vice-President (FIAIP, Italy), recalled that the short-term rental system is not only proposed by big online platforms but by real estate agencies as well. This type of rentals, in fact, is not only destined to tourists but it is also relevant for mobile workers and students. Luis de Prado, CEPI Vice-President (CGCAFE, Spain), underlined the need for reflection on how real estate and property management agencies on one side, and online short-term rental platforms on the other, could beneficially co-exist on the market. He emphasised that platforms should encourage their customers to respect rules concerning the quality of life of inhabitants and that more control of customers’ inappropriate behaviours should be put in place in order to avoid potential conflicts in the buildings. He called for a better organisation of this section of the rental market in order to find the best ways of coexistence between different operators.

(more…)

---